Clinical Trial: Alzheimer's Disease Neuroimaging Initiative 4
Study Status: Completed
Recruit Status: RECRUITING
Condition: Mild Cognitive Impairment
Study Type: OBSERVATIONAL
Official Title: Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)
Brief Summary:
Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) Study has been to validate biomarkers for Alzheimer's disease (AD) clinical trials.ADNI4 continues the previously funded ADNI1, ADNI-GO, ADNI2, and ADNI3 studies that have combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of AD.
Read more